{"id":12446,"date":"2026-09-22T11:18:13","date_gmt":"2026-09-22T11:18:13","guid":{"rendered":"https:\/\/gimm.pt\/?post_type=jobs&#038;p=12446"},"modified":"2026-09-22T11:18:13","modified_gmt":"2026-09-22T11:18:13","slug":"postdoctoral-researcher-reference-gimm-ct-35-2026","status":"publish","type":"jobs","link":"https:\/\/gimm.pt\/pt-pt\/jobs\/postdoctoral-researcher-reference-gimm-ct-35-2026\/","title":{"rendered":"Postdoctoral Researcher &#8211; Reference GIMM\/CT\/35-2026"},"content":{"rendered":"\n<p><strong>The GIMM \u2013 Gulbenkian Institute for Molecular Medicine<\/strong> is a pioneering Portuguese private research<br>foundation with an ambitious vision for fundamental scientific exploration and its profound impact on<br>global health and well-being. Founded in 2023, GI MM is the result of the merge of two leading research<br>institutes: Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes (iMM ) and Instituto Gulbenkian de<br>Ci\u00eancia (IGC) and dedicates to unraveling the fundamental mysteries of life and aims to be at the<br>forefront of transdisciplinary research.<\/p>\n\n\n\n<p><strong>What GIMM seeks:<\/strong> At this moment, GIMM is hiring a Postdoctoral Researcher to join the Chemical<br>Biology-Translational Research Lines -Care , coordinated by Ana Guerreiro , under the research project<br>HORIZON -EIC -2025-PATHFINDER VacciNEXT , funded by European Union , to execute the following<br>activities under the supervision of the project coordinator:<br>a) Execution of preclinical studies using murine tumour models;<br>b) Evaluation of vaccine efficacy, immune responses and antitumour activity;<br>c) Performance of immunological assays, including flow cytometry, ELISA and other immune<br>monitoring techniques;<br>d) Contribution to dissemination activities, preparation of scientific outputs related to the project,<br>project deliverables, and participation in consortium meetings.<\/p>\n\n\n\n<p><strong>Candidate\u2019s Profile<\/strong><br><strong><em>Mandatory Requirements:<\/em><\/strong><br>a) PhD degree in Immunology, Biology, Biochemistry, Biomedical Sciences or a related field.<br>b) Proven research experience in immunology, cancer immunology, immunotherapy, vaccine<br>development or related fields (minimum 3 years)<br>c) Experience with murine models and animal experimentation (minimum 2 years)<br>d) Excellent command of spoken and written English<br><strong><em>Desirable Requirements :<\/em><\/strong><br>a) Experience in mouse models of cancer.<br>b) Experience with flow cytometry.<br>c) Experience with ELISA, ELISpot and other immunological assays.<br>d) Experience in cell culture and immune cell isolation.<br>e) Experience in preclinical evaluation of vaccines and\/or immunotherapies.<br>f) FELASA certification (or equivalent training in laboratory animal science).<br>g) Ability to work independently and collaboratively in an international multidisciplinary team<\/p>\n\n\n\n<p><strong>What GI MM offers:<\/strong> GI MM offers outstanding working conditions , including a full-time and unfixed &#8211;<br>term employment contract predicted to start in October 2026 for the necessary period to execute the<br>work plan. Gross monthly salary of \u20ac2400 in accordance with the project budget and internal regulations,<br>as well as Holidays and Christmas allowances subject to the current mandatory taxes , accordingly to<br>Portuguese Labor Law. A meal allowance will also be paid in the amount of 10.20\u20ac per working day.<\/p>\n\n\n\n<p><strong>How to apply: <\/strong>Please submit your Motivation Letter, Detailed CV , References and PhD degree<br>certificate in PDF format to People &amp; Culture Team through the email positions@gimm.pt, with the<br>reference \u201cGIMM\/CT\/35-2026\u201d in the subject, from 23rd of September to 6th of October 2026.<br>Note: Candidates who incorrectly formalize their application or do not submit the documents proving<br>compliance with the requirements indicated in the call will be excluded. The jury has the right to request<br>any candidate, in case of doubt, to present documents proving their statements.<\/p>\n\n\n\n<p><strong>Non-discrimination and equal access policy : <\/strong>GIMM promotes a non-discrimination and equal access<br>policy, wherefore no candidate can be privileged, benefited, impaired or deprived of any rights<br>whatsoever, or be exempt of any duties based on their ancestry, age, sex, sexual preference, marital status, family and economic conditions, instruction, origin or social conditions, genetic heritage, reduced work capacity, disability, chronic illness, nationality, ethnic origin or race, origin territory, language, religion, political or ideological convictions an d union membership.<\/p>\n\n\n\n<p><strong>International environment and experience: <\/strong>Diversity is a fundamental aspect of the essence of GIMM,<br>where researchers and non-researchers of different nationalities, backgrounds and areas of study work<br>together, promoting the exchange of experiences and interactions, contributing to the personal and<br>professional development of each person and to the existence of an international, inclusive and<br>stimulating environment.<\/p>\n\n\n\n<p>Pursuant to Decree-Law nr 29\/2001 of 3rd February, disabled candidates shall be preferred in a situation<br>of equal classification, and said preference supersedes any legal preferences. Candidates must declare, on<br>their honour, their respective disability degree, type of disability and communication \/ expression means<br>to be used during selection period on their application form, under the regulations above.<\/p>\n\n\n\n<p><strong>Evaluation Criteria : <\/strong>Applications will be evaluated by Ana Guerreiro, Gon\u00e7alo Bernardes e Cong Tang ,<br>in accordance with the following method: Curricular Evaluation (80%) and Motivation Letter ( 20%);<\/p>\n\n\n\n<p><strong>Results:<\/strong> Both admitted and excluded candidates list and final classification list shall be communicated<br>to all admitted candidates through email.<\/p>\n\n\n\n<p><strong>Preliminary Hearing and Final Decision Deadline:<\/strong> After notification, all candidates have 10 working<br>days to respond. Panel\u2019s final decisions are pronounced within a period of 90 days, from application<br>deadline.<br><em>The present call is exclusively aimed at filling the indicated vacancy and may be terminated until the<br>homologation of the final candidates&#8217; ranking list and expires with the respective occupation of the<br>position on offer.<\/em><\/p>\n\n\n\n<p><strong>Lisbon, 22th of September of 2026<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/gimm.pt\/wp-content\/uploads\/2026\/09\/GIMM-CT-35-2026_eng.pdf\" data-type=\"link\" data-id=\"https:\/\/gimm.pt\/wp-content\/uploads\/2026\/09\/GIMM-CT-35-2026_eng.pdf\">Download the job offer<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/gimm.pt\/pt-pt\/wp-json\/wp\/v2\/jobs\/12446"}],"collection":[{"href":"https:\/\/gimm.pt\/pt-pt\/wp-json\/wp\/v2\/jobs"}],"about":[{"href":"https:\/\/gimm.pt\/pt-pt\/wp-json\/wp\/v2\/types\/jobs"}],"wp:attachment":[{"href":"https:\/\/gimm.pt\/pt-pt\/wp-json\/wp\/v2\/media?parent=12446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}